Thomas Englese

Thomas Englese is an experienced executive in the pharmaceutical and healthcare sectors, currently serving as Executive Vice President of Commercial at Tonix Pharmaceuticals since September 2024. Prior to this role, Thomas held the position of Chief Commercial Officer at Tris Pharma and Aziyo Biologics, Inc. from April 2023 to September 2024 and July 2019 to April 2023, respectively. Thomas's extensive experience at Mallinckrodt Pharmaceuticals involved significant leadership roles, including Senior Vice President & General Manager of Hospital Therapies, overseeing a $1 billion P&L, and Vice President & General Manager of Critical Care, managing a $750 million global business. Earlier career milestones include various positions at Baxter, focusing on business operations and analytics. Thomas graduated with a BS in Marketing from Villanova University and an MBA in Finance from Penn State University.